Literature DB >> 19590187

Excess of glucocorticoid induces cardiac dysfunction via activating angiotensin II pathway.

Sreerupa Ghose Roy1, Priyanka De, Debasri Mukherjee, Vivek Chander, Aditya Konar, Debasish Bandyopadhyay, Arun Bandyopadhyay.   

Abstract

BACKGROUND: Glucocorticoid is widely used as an anti-inflammatory drug in various diseases however excess of it often causes cardiovascular complications. The present study was undertaken to understand the molecular mechanism of glucocorticoid-induced cardiac dysfunction.
METHODS: Rats were treated daily with synthetic glucocorticoid, dexamethasone with or without mifepristone or losartan up to 15 days. Hemodynamic parameters were measured by PV-loop method using Millar's instrument. Cardiac remodelling, fibrosis and oxidative stress were monitored after 15 days.
RESULTS: The systolic blood pressure was increased whereas the heart beat and cardiac output (n=6) were decreased by dexamethasone. Dexamethasone caused increase in the heart weight to body weight ratio (P<0.001, n=20), increased level of mRNA of atrial natriuretic peptide and an increased deposition of collagens in the extracellular matrix of the left ventricle which were inhibited by both mifepristone and losartan. The rate of oxygen consumption was decreased in association with increased levels of hypoxia inducible factor 1alpha, lipid peroxidation (P<0.01, n=3) and superoxide dismutase activity (P<0.01, n=3) in dexamethasone treated rat heart. All these changes were reversed by mifepristone and losartan.
CONCLUSIONS: The excess of glucocorticoid induces cardiac remodelling and pathophysiolgical changes of the myocardium via angiotensin II signalling pathway. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590187     DOI: 10.1159/000227803

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  14 in total

Review 1.  A patient with erythema nodosus leprosum and Chagas cardiopathy: challenges in patient management and review of the literature.

Authors:  Maria Ângela B Trindade; Noemia B Carvalho; Elaini C Belfort; Carla Pagliari; Erika Gakiya; Neusa Y Sakai-Valente; Gil Benard; Maria A Shikanai-Yasuda
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia inducible factor-1α expression through the induction of glucocorticoid-induced leucine zipper.

Authors:  Wonchung Lim; Choa Park; Myeong Kuk Shim; Yong Hee Lee; You Mie Lee; YoungJoo Lee
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

3.  Loss of αB-crystallin function in zebrafish reveals critical roles in the development of the lens and stress resistance of the heart.

Authors:  Sanjay Mishra; Shu-Yu Wu; Alexandra W Fuller; Zhen Wang; Kristie L Rose; Kevin L Schey; Hassane S Mchaourab
Journal:  J Biol Chem       Date:  2017-11-21       Impact factor: 5.157

4.  Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment.

Authors:  Darren T Hwee; Aldrin V Gomes; Sue C Bodine
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-09       Impact factor: 4.310

5.  Glucocorticoid induced leucine zipper inhibits apoptosis of cardiomyocytes by doxorubicin.

Authors:  David Aguilar; Joshua Strom; Qin M Chen
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-28       Impact factor: 4.219

6.  Corticosteroids and aldose reductase inhibitor Epalrestat modulates cardiac action potential via Kvβ1.1 (AKR6A8) subunit of voltage-gated potassium channel.

Authors:  Jared Tur; Sachin L Badole; Feng Cheng; Aparoop Das; Rakesh C Kukreja; Srinivas M Tipparaju
Journal:  Mol Cell Biochem       Date:  2017-06-05       Impact factor: 3.396

7.  Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation.

Authors:  Fabiana de Salvi Guimarães; Wilson Max Almeida Monteiro de Moraes; Luis Henrique Marchesi Bozi; Pâmela R Souza; Ednei Luiz Antonio; Danilo Sales Bocalini; Paulo José Ferreira Tucci; Daniel Araki Ribeiro; Patricia Chakur Brum; Alessandra Medeiros
Journal:  Mol Cell Biochem       Date:  2016-10-19       Impact factor: 3.396

8.  Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients.

Authors:  B Shuai; Y P Yang; L Shen; R Zhu; X J Xu; C Ma; L Lv; J Zhao; J H Rong
Journal:  Osteoporos Int       Date:  2014-12-17       Impact factor: 4.507

9.  Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis.

Authors:  Zhang Yongtao; Wang Kunzheng; Zheng Jingjing; Shan Hu; Kou Jianqiang; Liu Ruiyu; Wang Chunsheng
Journal:  Endocrine       Date:  2014-02-12       Impact factor: 3.633

10.  Glucocorticoid modulates angiotensin II receptor expression patterns and protects the heart from ischemia and reperfusion injury.

Authors:  Qin Xue; Andrew J Patterson; Daliao Xiao; Lubo Zhang
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.